KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Shares Issued (2016)

Biogen (BIIB) has 8 years of Shares Issued data on record, last reported at $8.5 million in Q4 2016.

  • For Q4 2016, Shares Issued fell 2.3% year-over-year to $8.5 million; the TTM value through Dec 2016 reached $43.7 million, down 19.37%, while the annual FY2016 figure was $43.7 million, 19.37% down from the prior year.
  • Shares Issued reached $8.5 million in Q4 2016 per BIIB's latest filing, down from $11.3 million in the prior quarter.
  • Across five years, Shares Issued topped out at $25.6 million in Q1 2015 and bottomed at $8.5 million in Q4 2016.
  • Average Shares Issued over 5 years is $14.2 million, with a median of $11.3 million recorded in 2016.
  • Peak YoY movement for Shares Issued: crashed 90.24% in 2012, then grew 14.47% in 2015.
  • A 5-year view of Shares Issued shows it stood at $9.2 million in 2012, then skyrocketed by 136.76% to $21.8 million in 2013, then tumbled by 54.44% to $9.9 million in 2014, then dropped by 12.47% to $8.7 million in 2015, then fell by 2.3% to $8.5 million in 2016.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $8.5 million in Q4 2016, $11.3 million in Q3 2016, and $9.4 million in Q2 2016.